Guillain-Barré Syndrome During the COVID-19 Pandemic and Pre-pandemic Periods

Besharati, Alyeh; Saberi, Alia; Shirkouhi, Samaneh Ghorbani; Ashraf, Ali; Hatamian, Hamidreza; Kenarsari, Habib Eslami; Andalib, Sasan

doi:10.32598/cjns.8.28.213.2

Cited by 1 publication

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reduction in the number of GBS cases may be due to the protective measures introduced during the pandemic. However, based on data collected in Iran, no significant difference between the incidence of GBS cases before and during the pandemic was observed [ 74 ]. According to a cohort study conducted in India, there was a pandemic reduction in the number of cases, in this case of pediatric GBS, but the disease profile remained unchanged [ 75 ].…”

Section: Covid-19 and Guillain–barre Associationmentioning

confidence: 99%

The Impact of COVID-19 on the Guillain–Barré Syndrome Incidence

Kopańko,

Zabłudowska,

Zajkowska

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel its effects and discover new correlations between SARS-CoV-2 infection and changes in the organism that have occurred in patients. It has been shown that the disease can be associated with a variety of complications, including disorders of the nervous system such as a characteristic loss of smell and taste, as well as less commonly reported incidents such as cranial polyneuropathy or neuromuscular disorders. Nervous system diseases that are suspected to be related to COVID-19 include Guillain–Barré syndrome, which is frequently caused by viruses. During the course of the disease, autoimmunity destroys peripheral nerves, which despite its rare occurrence, can lead to serious consequences, such as symmetrical muscle weakness and deep reflexes, or even their complete abolition. Since the beginning of the pandemic, case reports suggesting a relationship between these two disease entities have been published, and in some countries, the increasing number of Guillain–Barré syndrome cases have also been reported. This suggests that previous contact with SARS-CoV-2 may have had an impact on their occurrence. This article is a review and summary of the literature that raises awareness of the neurological symptoms’ prevalence, including Guillain–Barré syndrome, which may be impacted by the commonly occurring COVID-19 disease or vaccination against it. The aim of this review was to better understand the mechanisms of the virus’s action on the nervous system, allowing for better detection and the prevention of its complications.

show abstract

Section: Covid-19 and Guillain–barre Associationmentioning

confidence: 99%